The Membrane Attack Mechanism of Complement. Verification of a Stable C5-9 Complex in Free Solution

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1973 Aug 1

PMID 4719679

Citations 30

Authors

W P KOLB

H J MULLER-EBERHARD

Affiliations

Soon will be listed here.

Abstract

The membrane attack mechanism of complement, C5 to C9, has previously been postulated to associate on the target cell surface to a stable decamolecular complex with a calculated mol wt of 995,000. A soluble and stable complex consisting of C5, C6, C7, C8, and C9 has now been demonstrated to arise as a consequence of complement activation by the classical or alternate pathway. It has a sedimentation coefficient of 22.5S and a mol wt of 1 million daltons, and it migrates on electrophoresis at pH 8.6 as an alpha-globulin. The stable and soluble C5b-9 complex cannot bind to erythrocytes and has no demonstrable cytolytic activity. However, due to partially unsaturated binding sites for C9, it can bind additional C9 and thus function as an inhibitor of lysis of EAC1-8 by C9. These results support the concept according to which the membrane-bound attack system of complement represents a stable, decamolecular assembly of C5b-9. Unlike its analogue in free solution, the membrane-bound complex is cytolytically active.

Citing Articles

ABO blood group antigen therapy: a potential new strategy against solid tumors.

Luo Q, Pan M, Feng H, Wang L Sci Rep. 2021; 11(1):16241.

PMID: 34376742 PMC: 8355358. DOI: 10.1038/s41598-021-95794-x.

Soluble Membrane Attack Complex: Biochemistry and Immunobiology.

Barnum S, Bubeck D, Schein T Front Immunol. 2020; 11:585108.

PMID: 33240274 PMC: 7683570. DOI: 10.3389/fimmu.2020.585108.

Plasma levels of soluble membrane attack complex are elevated despite viral suppression in HIV patients with poor immune reconstitution.

Schein T, Blackburn T, Heath S, Barnum S Clin Exp Immunol. 2019; 198(3):359-366.

PMID: 31461782 PMC: 6857077. DOI: 10.1111/cei.13366.

Re-incorporation of the terminal C5b-9 complement complex into lipid bilayers: formation and stability of reconstituted liposomes.

Bhakdi S, Tranum-Jensen J Immunology. 1980; 41(3):737-42.

PMID: 7461711 PMC: 1458153.

Ultrastructure of the membrane attack complex of complement: detection of the tetramolecular C9-polymerizing complex C5b-8.

Tschopp J, Podack E, MULLER-EBERHARD H Proc Natl Acad Sci U S A. 1982; 79(23):7474-8.

PMID: 6961424 PMC: 347362. DOI: 10.1073/pnas.79.23.7474.

References

Andrews P . The gel-filtration behaviour of proteins related to their molecular weights over a wide range. Biochem J. 1965; 96(3):595-606. PMC: 1207193. DOI: 10.1042/bj0960595. View

Nilsson U, MUELLER-EBERHARD H . ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. J Exp Med. 1965; 122:277-98. PMC: 2138056. DOI: 10.1084/jem.122.2.277. View

Nilsson U, MULLER-EBERHARD H . Studies on the mode of action of the fifth, sixth and seventh component of human complement in immune haemolysis. Immunology. 1967; 13(1):101-17. PMC: 1409155. View

Polley M, MULLER-EBERHARD H . Enharncement of the hemolytic activity of the second component of human complement by oxidation. J Exp Med. 1967; 126(6):1013-25. PMC: 2138419. DOI: 10.1084/jem.126.6.1013. View

HADDING U, MULLER-EBERHARD H . The ninth component of human complement: isolation, description and mode of action. Immunology. 1969; 16(6):719-35. PMC: 1409673. View

Manni J, MULLER-EBERHARD H . The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency. J Exp Med. 1969; 130(5):1145-60. PMC: 2180480. DOI: 10.1084/jem.130.5.1145. View

Thompson R, LACHMANN P . Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7. J Exp Med. 1970; 131(4):629-41. PMC: 2138783. DOI: 10.1084/jem.131.4.629. View

LACHMANN P, Thompson R . Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. J Exp Med. 1970; 131(4):643-57. PMC: 2138770. DOI: 10.1084/jem.131.4.643. View

Cooper N, Polley M, MULLER-EBERHARD H . The second component of human complement (C2): quantitative molecular analysis of its reactions in immune hemolysis. Immunochemistry. 1970; 7(4):341-56. DOI: 10.1016/0019-2791(70)90237-5. View

10.

Gotze O, MULLER-EBERHARD H . Lysis of erythrocytes by complement in the absence of antibody. J Exp Med. 1970; 132(5):898-915. PMC: 2138874. DOI: 10.1084/jem.132.5.898. View

11.

Shin H, Pickering R, Mayer M . The fifth component of the guinea pig complement system. II. Mechanism of SAC1,4,2,3,5b formation and C5 consumption by EAC1,4,2,3. J Immunol. 1971; 106(2):473-9. View

12.

Cooper N, MULLER-EBERHARD H . The reaction mechanism of human C5 in immune hemolysis. J Exp Med. 1970; 132(4):775-93. PMC: 2138854. DOI: 10.1084/jem.132.4.775. View

13.

MULLER-EBERHARD H, FJELLSTROM K . Isolation of the anticomplementary protein from cobra venom and its mode of action on C3. J Immunol. 1971; 107(6):1666-72. View

14.

KOLB W, Haxby J, Arroyave C, MULLER-EBERHARD H . Molecular analysis of the membrane attack mechanism of complement. J Exp Med. 1972; 135(3):549-66. PMC: 2139138. DOI: 10.1084/jem.135.3.549. View

15.

Arroyave C, MULLER-EBERHARD H . Isolation of the sixth component of complement from human serum. Immunochemistry. 1971; 8(11):995-1006. DOI: 10.1016/0019-2791(71)90487-3. View

16.

MULLER-EBERHARD H, Gotze O . C3 proactivator convertase and its mode of action. J Exp Med. 1972; 135(4):1003-8. PMC: 2139164. DOI: 10.1084/jem.135.4.1003. View

17.

Koethe S, Austen K, Gigli I . Blocking of the hemolytic expression of the classical complement sequence by products of complement activation via the alternate pathway. Materials responsible for the blocking phenomenon and their proposed mechanism of action. J Immunol. 1973; 110(2):390-400. View

18.

KOLB W, Haxby J, Arroyave C, MULLER-EBERHARD H . The membrane attack mechanism of complement. Reversible interactions among the five native components in free solution. J Exp Med. 1973; 138(2):428-37. PMC: 2139403. DOI: 10.1084/jem.138.2.428. View

19.

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

20.

McCONAHEY P, Dixon F . A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol. 1966; 29(2):185-9. DOI: 10.1159/000229699. View